Machine Learning and Artificial Intelligence in Nanomedicine
WIREs Nanomedicine and Nanobiotechnology · 2025-07 · 17 (4)
DOI: 10.1002/wnan.70027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 14.08.2025. Verfasst von Wei-Chun Chou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Sciences, University of California, Riverside, California, USA. Hauptthemen laut MEDLINE: Nanomedicine, Machine Learning, Artificial Intelligence. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering.
Abstract (Originalsprache)
Nanomedicine harnesses nanoscale materials, such as lipid, polymeric, and inorganic nanoparticles, to deliver diagnostic or therapeutic agents for cancer, infectious disease, and neurological disorders, among others. However, translating promising nanoparticle designs into clinically approved products remains a challenge. Factors such as particle size, surface chemistry, and payload interactions must be optimized, and preclinical results often fail to predict human efficacy. In recent years, artificial intelligence (AI) and machine learning (ML) have emerged as transformative tools to address these hurdles at every stage of nanomedicine development. By rapidly screening extensive libraries and extracting structure–function relationships, AI‐driven models can rationalize nanoparticle formulation, predict biodistribution, and guide optimal design. Techniques like high‐throughput DNA barcoding and automated liquid handling facilitate robust, large‐scale data collection, feeding into computational pipelines that expedite discovery while reducing reliance on resource‐intensive trial‐and‐error experiments. AI‐based platforms also enable improved modeling of protein corona formation, which profoundly affects nanoparticle immunogenicity and cellular uptake. Despite these advances, challenges persist in data standardization, model generalizability, and establishing a clear regulatory framework since no dedicated U.S. Food and Drug Administration (FDA) guidance addresses the intersection of AI and nanomedicine. Overcoming these limitations requires harmonized data sharing, rigorous in vivo validation, and clear ethical and regulatory guidelines. This review summarizes the rapidly evolving landscape of AI in nanomedicine, highlighting key successes in design and preclinical prediction, as well as persistent obstacles to full‐scale clinical integration. By illuminating these dynamics, we aim to chart a more efficient path forward in developing next‐generation nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Environmental Sciences, University of California, Riverside, California, USA.
- Environmental Toxicology Graduate Program, University of California, Riverside, California, USA.
- Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
- Center for Environmental and Human Toxicology, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Alexa Canchola, Zhoumeng Lin
Förderung
- NIBIB NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Chou, W. C., Canchola, A., Zhang, F., & Lin, Z. (2025). Machine Learning and Artificial Intelligence in Nanomedicine. WIREs Nanomedicine and Nanobiotechnology, 17(4). https://doi.org/10.1002/wnan.70027
Vancouver
Chou WC, Canchola A, Zhang F, Lin Z. Machine Learning and Artificial Intelligence in Nanomedicine. WIREs Nanomedicine and Nanobiotechnology. 2025;17(4). doi:10.1002/wnan.70027
BibTeX
@article{Chou2025,
author = {Chou, Wei-Chun and Canchola, Alexa and Zhang, Fan and Lin, Zhoumeng},
title = {Machine Learning and Artificial Intelligence in Nanomedicine},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2025},
volume = {17},
number = {4},
doi = {10.1002/wnan.70027}
}
EUVIMED